One of the few areas where most nations cooperate is in infectious disease control. For nation states, cooperation is the best option in this type of ‘prisoner’s dilemma‘.
“On 31 December 2019, the World Health Organization was alerted about a cluster of pneumonia cases of unknown etiology in Wuhan, China, which prompted international concern of the potential public-health impact of an outbreak of a new virus [COVID-19] … With the now global spread of the virus, the urgency of a coordinated international response has amplified … This multi-pronged approach to curtail the outbreak, strongly supported by existing R&D, is a testament to the collaborative response of international organizations and the research and clinical communities … The initial global response to the 2019-nCoV outbreak illustrates the power of rapid communication and the importance of sustained research and collaborations that can be leveraged in future outbreaks. Sustained cooperation is essential to their resolution.” —Nature 2020-02-03
In Canada, special funds of up to $1 million per project have been allocated for rapid research into the recent outbreak of the novel corona virus [COVID-19]. Other nations, institutions, and corporations are also cooperating on molecular assays to diagnose COVID-19, including — China, Germany, Hong Kong, Japan, Thailand, USA. A special English-Chinese translation engine for scientific and medical use is being made freely available to researchers around the world by UK-based St. John’s Innovation Centre.